PAR-22-250 - Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 2
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Supporting Data Sciences Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program | NOT-GM-23-011 | NIGMS , ODSS | Oct 31, 2022 | Jan 31, 2025 | P20 |
Notice of Special Interest (NOSI): Supporting Womens Health Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program | NOT-GM-23-012 | NIGMS , ORWH | Oct 27, 2022 | Jan 31, 2025 | P20 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|